Vaccines, Diagnostics and Therapeutics as Global Public Goods

BANGKOK, Thailand, Dec 20 (IPS) – Countries in the Asia-Pacific region are trying their best to deal with the COVID-19 pandemic by rapidly rolling out vaccination programmes and putting in place public health interventions to reduce its impact. At the end of November, there were 262 million confirmed COVID-19 cases and 5.2 million deaths globally. About 60 per cent of all COVID-19 cases and half of all COVID-19 related deaths were in Asia and the Pacific. About 7.8 billion vaccines have been administered globally, and vaccine supply is generally improving.

Read the full story, “Vaccines, Diagnostics and Therapeutics as Global Public Goods”, on globalissues.org →